Food and Drug Administration officials have approved another generic version of the abortion pill mifepristone.

The Associated Press reported that drugmaker Evita Solutions shared on its website that the FDA authorized its low-cost form of the pill, which is approved to end pregnancies through 10 weeks.

An FDA spokesperson told the AP that the agency "has very limited discretion in deciding whether to approve a generic drug," and added that FDA officials do not "endorse any product."

In an email from Evita Solutions obtained by the AP, the company said the drug is expected to roll out in January 2026.

Has the FDA approved mifepristone in the past?

The backstory:

In 2000, the Food and Drug Administration authorized the original version of mifepristone and made it more accessible throu

See Full Page